You're Taking Fish Oil Faithfully. Your Genes May Be Why It Isn't Working.

Your CYP2D6 gene produces an enzyme that sits in your liver and lungs, breaking down a staggering range of substances. It’s one of your body’s primary detoxification pathways for everything from antidepressants to fish oil metabolites. If this gene works well, compounds enter your cells, get processed, and exit efficiently. If it doesn’t, things accumulate.

The problem: certain variants in CYP2D6 slow it down dramatically. Poor metabolizers, who carry loss-of-function variants, make up roughly 7-10% of people with European ancestry. If you’re a poor metabolizer, fish oil components accumulate in your bloodstream instead of being processed into active forms. Even worse, other supplements or medications in that same pathway back up like traffic at a one-lane bridge.

In day-to-day life, this means fish oil sits in your system without triggering the anti-inflammatory cascade you’re hoping for. Your joints still ache. Your blood lipids don’t improve. You feel like you’re taking an expensive placebo.

CYP2C19 is a second critical liver enzyme that metabolizes certain classes of drugs and supplement-active compounds. It’s especially important for anything that requires activation in the liver before it can do its job. Clopidogrel, for instance, is a prodrug. It’s inert until CYP2C19 activates it. If you can’t activate it, it doesn’t work.

Here’s where fish oil and similar lipid supplements come in: their metabolic fate depends partly on CYP2C19 function. Poor metabolizers, carrying *2 or *3 variants, represent roughly 2-15% of the population depending on your ancestry. If you’re a poor metabolizer, fish oil components move through your system without being properly processed into their active, anti-inflammatory forms. The omega-3s might reach your bloodstream, but they won’t trigger the cellular effects you’re paying for.

You notice this because the supplement doesn’t seem to touch inflammation markers. You take it for months, your doctor runs lipid labs, and nothing has budged. The supplement isn’t broken. Your ability to activate it is.

CYP2C9 is responsible for breaking down NSAIDs and other anti-inflammatory compounds. If you’re taking fish oil partly because NSAIDs upset your stomach, this gene is especially relevant. It controls how quickly inflammation-modulating compounds move through your system. Poor metabolizer variants (*2, *3) exist in roughly 5-10% of people with European ancestry.

If you have a CYP2C9 variant that slows metabolism, fish oil and related supplements accumulate to higher-than-expected levels in your bloodstream. This might sound good (more should be better, right?), but it can actually create problems. Accumulation can lead to bleeding risk in some cases, especially if you’re also taking other anticoagulants or NSAIDs. Your body can’t clear the supplement fast enough.

The lived experience is confusing. You take fish oil specifically to reduce inflammation without NSAID side effects, but you don’t see improvement, or you develop unexpected bruising or bleeding. The supplement isn’t helping your inflammation, and it’s creating new problems. This is a sign your body can’t process it efficiently.

SLCO1B1 is not an enzyme. It’s a transporter. Think of it as the bouncer at the door to your liver cells. This protein grabs lipid-based compounds from your bloodstream and pulls them inside so they can be processed. If this transporter works well, fish oil moves efficiently from blood into liver cells. If it doesn’t, fish oil stays stuck in circulation.

The *5 variant in SLCO1B1 (specifically rs4149056), carried by roughly 15% of the population, reduces the transport capacity for lipid compounds, meaning fish oil can’t efficiently enter your liver cells for processing and metabolism. You absorb the fish oil in your gut. It enters your bloodstream. But then it gets stuck outside your cells because the transporter is slow or inefficient. Your bloodwork might even show decent omega-3 levels, but they’re not getting inside your cells where they need to be to reduce inflammation.

You feel this as a failure. You’re doing everything right. Your supplement is hitting your bloodstream. But nothing is happening. Your inflammation markers don’t move. Your doctor has no explanation because standard bloodwork shows the omega-3s are present. Nobody checks whether they’re actually inside your cells.

VKORC1 is your vitamin K epoxide reductase. It recycles vitamin K in your cells, and this process is essential for blood clotting balance and bone metabolism. Fish oil affects coagulation, and VKORC1 is part of how your body manages that balance. If VKORC1 is overactive, your vitamin K recycling is efficient. If the -1639G>A variant slows it down, your vitamin K efficiency drops.

The A allele, present in roughly 40% of people with European ancestry, reduces vitamin K recycling efficiency, making you more sensitive to anything that affects coagulation, including fish oil. You might take fish oil thinking it will thin your blood slightly to improve circulation, but your body’s ability to balance that effect with vitamin K is compromised. You’re more prone to bleeding or bruising, or you develop unexpected interactions with other supplements or medications that affect clotting.

This manifests as unexpected bleeding, easy bruising, or worse, your doctor telling you to stop the fish oil because your INR is too high or your bleeding time is prolonged. You feel like you took a supplement to help yourself and it backfired. The problem wasn’t the fish oil. It was your VKORC1 function colliding with the supplement’s effects.

MTHFR produces the enzyme that converts dietary folate into methylfolate, the active form your cells use for DNA repair, detoxification, and hundreds of other processes. Fish oil doesn’t directly depend on MTHFR for metabolism, but the inflammatory state that fish oil is supposed to reduce does. If your MTHFR is compromised, your cells are in a chronic state of poor methylation, oxidative stress, and impaired detoxification. Fish oil might be excellent, but your cells are too depleted to benefit from it.

The C677T variant, present in roughly 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40-70%, creating a cascade of downstream metabolic problems that makes your cells resistant to fish oil’s benefits. Your body is too busy trying to handle basic methylation to properly utilize the anti-inflammatory compounds fish oil is delivering. It’s like trying to paint a room that’s on fire. The paint (fish oil) is good. The room (your cellular methylation) is the problem.

You experience this as persistent inflammation despite the supplement, chronic fatigue, poor recovery after exercise, and a sense that nothing you take makes much difference. Your cells are depleted at the methylation level, and until you fix that, fish oil alone won’t move the needle.